Atherosclerotic neovasculature MR imaging with mixed manganese-gadolinium nanocolloids in hyperlipidemic rabbits - Wikidata - awgldk - TriplyDB

Atherosclerotic neovasculature MR imaging with mixed manganese-gadolinium nanocolloids in hyperlipidemic rabbits

Atherosclerotic neovasculature MR imaging with mixed manganese-gadolinium nanocolloids in hyperlipidemic rabbits

http://www.wikidata.org/entity/Q36483514

about

Dual-therapy with αvβ3-targeted Sn2 lipase-labile fumagillin-prodrug nanoparticles and zoledronic acid in the Vx2 rabbit tumor model.Ultrasound and magnetic resonance molecular imaging of atherosclerotic neovasculature with perfluorocarbon magnetic nanocapsules targeted against vascular endothelial growth factor receptor 2 in rats.

P2860

Q36505441-802F9435-FF30-4ECD-9615-58D300AC3636 Q38604554-0E7F4F01-0319-41DE-AF05-0F536EBFCBA6

P2860

Atherosclerotic neovasculature MR imaging with mixed manganese-gadolinium nanocolloids in hyperlipidemic rabbits

http://www.wikidata.org/entity/Q36483514

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Atherosclerotic neovasculature ...... oids in hyperlipidemic rabbits

@ast

Atherosclerotic neovasculature ...... oids in hyperlipidemic rabbits

@en

type

label

Atherosclerotic neovasculature ...... oids in hyperlipidemic rabbits

@ast

Atherosclerotic neovasculature ...... oids in hyperlipidemic rabbits

@en

prefLabel

Atherosclerotic neovasculature ...... oids in hyperlipidemic rabbits

@ast

Atherosclerotic neovasculature ...... oids in hyperlipidemic rabbits

@en

P1433

Q36483514-02B601F8-0636-4A38-A36E-CB54D7FB8BCD

P1476

Q36483514-19592857-5D7D-4B29-A917-9BF697D59EE9

P2093

Q36483514-03332831-A117-40CD-9FA9-99649547EF22

Q36483514-0AA9C3D6-897C-4632-BF61-9B345F5EB1B8

Q36483514-21A02293-5A07-45D7-A197-09E0887BC131

Q36483514-35275DD4-817D-47B0-8501-D8ACF4621525

Q36483514-48DFF0A7-99F6-43C5-9D9E-DB0FEDD81892

Q36483514-68E8F5DA-BCED-4FA2-AB79-7795AAEC7834

Q36483514-73664921-FE33-4F35-8F8D-507A7721CD5D

Q36483514-C2C390BA-B0F4-4B75-B888-7812DE834BBE

Q36483514-F74F8F1B-8594-49BD-AED4-8ED0DFFEEEE0

P2860

Q36483514-00E5A27C-E3C4-4361-960D-2BECF1AD357A

Q36483514-0279EC1B-6E0E-442A-BDA0-353E080DE5BB

Q36483514-08E6F9F3-471C-47C4-9AFD-66BFF5B58AF7

Q36483514-10ACA369-1969-4804-B4C0-B25F1021D9F5

Q36483514-24EDAF6E-0C30-402D-87CA-81B402C3D45D

Q36483514-36239F95-F30F-48C6-BE59-13E3FFB7FE39

Q36483514-4C28C58D-CFFB-4F24-BA2D-A2EABB7BA02D

Q36483514-4D418237-FC87-4749-BB71-AF234E2930BB

Q36483514-50B10202-EC7F-4374-9EC1-9532CE4F630D

Q36483514-5338F6A7-78A6-44B5-BD5E-82D5FAFB29A6

P304

Q36483514-77DBB840-5E73-468C-8814-7586AA7F8551

P31

Q36483514-C5EBD77D-BC93-4B2B-A037-AAD7A7D19DF9

P356

Q36483514-192E1BA4-5E88-4700-A985-01C29AFE4573

P433

Q36483514-866E896F-EE78-462B-B29F-15D0DCBD0887

P478

Q36483514-4B6D0790-F48E-466C-85DE-8D545DBFC40E

P50

Q36483514-87D52D8F-ED56-4ABC-822C-C7472052CF0E

P577

Q36483514-42E43699-5E09-4ABD-8D1E-8CC39E00A7CC

P5875

Q36483514-DE82882A-BCB6-49FD-BB49-48811222AB49

P698

Q36483514-0073D53F-EA94-4B98-8222-A89EEE01ABC2

P921

Q36483514-2E16D084-8EEB-4BAE-B4F2-9563C3B9112B

Q36483514-B80F8719-CAEE-4E54-91CF-5BE6CEFFDFCE

P932

Q36483514-EBE5E1B2-F718-4A67-8619-2790543B2D33

P356

J.NANO.2014.12.008

P1433

Nanomedicine: Nanotechnology, Biology and Medicine

P1476

Atherosclerotic neovasculature ...... oids in hyperlipidemic rabbits

@en

P2093

Angana Senpan

http://www.w3.org/2001/XMLSchema#string

Anne H Schmieder

http://www.w3.org/2001/XMLSchema#string

Baozhong Shen

http://www.w3.org/2001/XMLSchema#string

Grace Cui

http://www.w3.org/2001/XMLSchema#string

Gregory M Lanza

http://www.w3.org/2001/XMLSchema#string

Huiying Zhang

http://www.w3.org/2001/XMLSchema#string

John S Allen

http://www.w3.org/2001/XMLSchema#string

Kezheng Wang

http://www.w3.org/2001/XMLSchema#string

Shelton D Caruthers

http://www.w3.org/2001/XMLSchema#string

P2860

Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

Executive Summary: Heart Disease and Stroke Statistics--2012 Update: A Report From the American Heart Association

Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

Molecular photoacoustic imaging of angiogenesis with integrin-targeted gold nanobeacons.

Synthesis and evaluation of a high relaxivity manganese(II)-based MRI contrast agent.

Relaxivity of liposomal paramagnetic MRI contrast agents.

Manganism and idiopathic parkinsonism: similarities and differences.

Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction.

Variable antibody-dependent activation of complement by functionalized phospholipid nanoparticle surfaces.

P304

569-578

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NANO.2014.12.008

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272081696

http://www.w3.org/2001/XMLSchema#string

P698

25652897

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

4720435

http://www.w3.org/2001/XMLSchema#string